arrow
S

Satya Das

Ohio State University
H指数:20
被引数:5,384

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

NCI 10211: a phase II, single-arm study of berzosertib in combination with irinotecan in patients with advanced TP53 mutant gastroesophageal cancer

NCI 10211:一项伯佐塞蒂布与伊立替康联合治疗TP53突变型晚期胃肠癌的II期单臂研究

2025-12-010
OAAI
Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting

2021国家癌症研究所神经内分泌肿瘤临床试验计划会议共识报告

2023-05-311
OA
Efficacy and toxicity of anti-vascular endothelial growth receptor tyrosine kinase inhibitors in patients with neuroendocrine tumours- A systematic review and meta-analysis

神经内分泌肿瘤患者抗血管内皮生长受体酪氨酸激酶抑制剂的疗效和毒性-系统评价和meta分析

2023-03-013
OAAI